These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 10470288)

  • 41. Detection of Circulating Tumor Cells in Breast Cancer Patients Using Cytokeratin-19 Real-Time RT-PCR.
    Park HS; Han HJ; Lee S; Kim GM; Park S; Choi YA; Lee JD; Kim GM; Sohn J; Kim SI
    Yonsei Med J; 2017 Jan; 58(1):19-26. PubMed ID: 27873491
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Haematogenous cytokeratin 20 mRNA as a predictive marker for recurrence in oral cancer patients.
    Kawamata H; Uchida D; Nakashiro K; Hino S; Omotehara F; Yoshida H; Sato M
    Br J Cancer; 1999 May; 80(3-4):448-52. PubMed ID: 10408852
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Detection of peritoneal micrometastases by reverse transcriptase-polymerase chain reaction targeting carcinoembryonic antigen and cytokeratin 20 in colon cancer patients.
    Aoki S; Takagi Y; Hayakawa M; Yamaguchi K; Futamura M; Kunieda K; Saji S
    J Exp Clin Cancer Res; 2002 Dec; 21(4):555-62. PubMed ID: 12636102
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Detection of circulating breast cancer cells by reverse transcriptase polymerase chain reaction (RT-PCR).
    Hu XC; Chow LW
    Eur J Surg Oncol; 2000 Sep; 26(6):530-5. PubMed ID: 11034801
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic impact of CK-20-positive cells in peripheral venous blood of patients with gastrointestinal carcinoma.
    Friederichs J; Gertler R; Rosenberg R; Nahrig J; Führer K; Holzmann B; Dittler HJ; Dahm M; Thorban S; Nekarda H; Siewert JR
    World J Surg; 2005 Apr; 29(4):422-8. PubMed ID: 15770378
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunohistochemical detection of uroplakin III, cytokeratin 7, and cytokeratin 20 in canine urothelial tumors.
    Ramos-Vara JA; Miller MA; Boucher M; Roudabush A; Johnson GC
    Vet Pathol; 2003 Jan; 40(1):55-62. PubMed ID: 12627713
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Urinary cytokeratin 20 mRNA expression has the potential to predict recurrence in superficial transitional cell carcinoma of the bladder.
    Christoph F; Weikert S; Wolff I; Schostak M; Tabiti K; Müller M; Miller K; Schrader M
    Cancer Lett; 2007 Jan; 245(1-2):121-6. PubMed ID: 16473461
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Detection of circulating tumor cells from peripheral blood in patients with transitional cell carcinoma--pilot study. Comparison with the standard histopathological staging].
    Nagy V; Rosocha J; Zidzik J; Bohus P
    Klin Onkol; 2011; 24(4):287-92. PubMed ID: 21905620
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Increased detection of circulating tumor cells in the blood of colorectal carcinoma patients using two reverse transcription-PCR assays and multiple blood samples.
    Wharton RQ; Jonas SK; Glover C; Khan ZA; Klokouzas A; Quinn H; Henry M; Allen-Mersh TG
    Clin Cancer Res; 1999 Dec; 5(12):4158-63. PubMed ID: 10632355
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Quantitative real-time RT-PCR for detection of disseminated tumor cells in peripheral blood of patients with colorectal cancer using different mRNA markers.
    Schuster R; Max N; Mann B; Heufelder K; Thilo F; Gröne J; Rokos F; Buhr HJ; Thiel E; Keilholz U
    Int J Cancer; 2004 Jan; 108(2):219-27. PubMed ID: 14639606
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Urinary cytokeratin 20 as a marker for transitional cell carcinoma.
    Rotem D; Cassel A; Lindenfeld N; Mecz Y; Sova Y; Resnick M; Stein A
    Eur Urol; 2000 May; 37(5):601-4. PubMed ID: 10765100
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Limitations of cytokeratin 20 RT-PCR to detect disseminated tumour cells in blood and bone marrow of patients with colorectal cancer: expression in controls and downregulation in tumour tissue.
    Vlems FA; Diepstra JH; Cornelissen IM; Ruers TJ; Ligtenberg MJ; Punt CJ; van Krieken JH; Wobbes T; van Muijen GN
    Mol Pathol; 2002 Jun; 55(3):156-63. PubMed ID: 12032226
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cytokeratin 20 is not a reliable molecular marker for occult breast cancer cell detection in hematological tissues.
    Silva AL; Diamond J; Silva MR; Passos-Coelho JL
    Breast Cancer Res Treat; 2001 Mar; 66(1):59-66. PubMed ID: 11368411
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Correspondence re: B. Molnar et al., Circulating tumor cell clusters in the peripheral blood of colorectal cancer patients. Clin. Cancer Res., 7: 4080-4085, 2001.
    Tsavellas G; Huang A
    Clin Cancer Res; 2002 Jun; 8(6):2015; author reply 2016-7. PubMed ID: 12060648
    [No Abstract]   [Full Text] [Related]  

  • 55. CK20 gene expression: technical limits for the detection of circulating tumor cells.
    Champelovier P; Mongelard F; Seigneurin D
    Anticancer Res; 1999; 19(3A):2073-8. PubMed ID: 10470150
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Detection of cytokeratin-19 transcripts by reverse transcriptase-polymerase chain reaction in lung cancer cell lines and blood of lung cancer patients.
    Dingemans AM; Brakenhoff RH; Postmus PE; Giaccone G
    Lab Invest; 1997 Sep; 77(3):213-20. PubMed ID: 9314945
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Detection of circulating breast cancer cells in peripheral blood by a two-marker reverse transcriptase-polymerase chain reaction assay.
    Fabisiewicz A; Kulik J; Kober P; Brewczyńska E; Pieńkowski T; Siedlecki JA
    Acta Biochim Pol; 2004; 51(3):747-55. PubMed ID: 15448736
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Detection of bone marrow-disseminated breast cancer cells using an RT-PCR assay of MUC5B mRNA.
    Berois N; Varangot M; Sóñora C; Zarantonelli L; Pressa C; Laviña R; Rodríguez JL; Delgado F; Porchet N; Aubert JP; Osinaga E
    Int J Cancer; 2003 Feb; 103(4):550-5. PubMed ID: 12478674
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular detection of disseminated tumor cells in the peripheral blood in patients with gastrointestinal cancer.
    Huang P; Wang J; Guo Y; Xie W
    J Cancer Res Clin Oncol; 2003 Mar; 129(3):192-8. PubMed ID: 12684893
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction.
    Datta YH; Adams PT; Drobyski WR; Ethier SP; Terry VH; Roth MS
    J Clin Oncol; 1994 Mar; 12(3):475-82. PubMed ID: 7509852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.